“Lower mortality rate, better clinical status, and shorter duration of invasive ventilation were observed in hospitalised patients with COVID-19 treated with imatinib during a 90-day follow-up” A long-term clinical outcomes analysis of COVID-19 patients treated with imatinib has recently been published in The Lancet Respiratory Medicine. The study, performed at VUmc, reviewed the 90-day outcomes […]
